Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma

Bone destruction is a hallmark of multiple myeloma and affects more than 80% of patients. However, current therapy is unable to completely cure and/or prevent bone lesions. Although it is accepted that myeloma cells mediate bone destruction by inhibition of osteoblasts and activation of osteoclasts,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jing, He, Jin, Wang, Ji, Cao, Yabing, Ling, Jianhua, Qian, Jianfei, Lu, Yong, Li, Haiyan, Zheng, Yuhuan, Lan, Yongsheng, Hong, Sungyoul, Matthews, Jairo, Starbuck, Michael W, Navone, Nora M, Orlowski, Robert Z., Lin, Pei, Kwak, Larry W., Yi, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381862/
https://www.ncbi.nlm.nih.gov/pubmed/22425892
http://dx.doi.org/10.1038/leu.2012.71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381862/
https://www.ncbi.nlm.nih.gov/pubmed/22425892
http://dx.doi.org/10.1038/leu.2012.71

Ejemplares similares